DUOX2 and pancreatic neoplasm: As a potent oncogene, the expression of DUOX2 has been shown to be significantly upregulated in several cancer types including lung, cervical, colon, rectal, stomach, and pancreatic cancers when compared with adjacent nonmalignant tissues [9–15].